Both in Pharmaceuticals
Vistagen Therapeutics vs Soligenix
Over the past year VTGN returned −96.0% and SNGX returned −75.0%; their daily moves had a correlation of 0.10.
VTGN −96.0% SNGX −75.0%Growth of $1, one year, split-adjusted
| Metric | VTGN | SNGX |
|---|---|---|
| Price | $0.1697 | $0.3678 |
| Market cap | $7.5M | $8.0M |
| Today | +0.83% | +3.34% |
| 1 month | −39.6% | +0.7% |
| 6 months | −72.7% | +6.6% |
| Year to date | −74.4% | −72.6% |
| 1 year | −95.5% | −75.6% |
| Revenue growth (YoY) | +504.9% | — |
| Gross margin | 100.0% | — |
| Net margin | −882.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 3.0× | — |
| Net cash | $31.7M | $9.8M |
| Dividend yield | — | — |
| Volatility (60d) | 106.5% | 41.9% |
| Short % of float | 5.7% | 0.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).